共 50 条
- [1] ALK AND EGFR MUTATION ANALYSIS IN A PHASE II TRIAL OF CISPLATIN/PEMETREXED IN JAPANESE PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCERANNALS OF ONCOLOGY, 2012, 23 : 418 - 418Yanagitani, N.Kaburaki, K.Ohyanagi, F.Kudo, K.Horiike, A.Motoi, N.Takeuchi, K.Ishikawa, Y.Horai, T.Nishio, M.
- [2] Phase II trial of bevacizumab, cisplatin, and pemetrexed in Japanese patients with advanced nonsquamous non-small cell lung cancer.JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)Yanagitani, NorikoOhyanagi, FumiyoshiNishizawa, HironariGyotoku, HiroshiUenami, TakeshiKobayashi, HlroshiKudo, KeltaTambo, YuichiHorilke, AtsushiHagiwara, SachikoHorai, TakeshiNishio, Makoto
- [3] Pharmacogenetic study of Japanese patients with advanced nonsquamous non-small cell lung cancer treated with pemetrexed plus cisplatinJOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)Imai, HisaoSerizawa, MasakuniTakahashi, ToshiakiMori, KeitaOno, AkiraAkamatsu, HiroakiTaira, TetsuhikoNakamura, YukikoKenmotsu, HirotsuguNaito, TateakiMurakami, HaruyasuKoh, YasuhiroEndo, MasahiroNakajima, TakashiYamamoto, Nobuyuki
- [4] Pemetrexed and Cisplatin for Advanced Non-squamous Non-small Cell Lung Cancer in Japanese Patients: Phase II StudyANTICANCER RESEARCH, 2013, 33 (08) : 3327 - 3333Kawano, YukoOhyanagi, FumiyoshiYanagitani, NorikoKudo, KeitaHoriike, AtsushiTanimoto, AzusaNishizawa, HironariIchikawa, AtsuoSakatani, ToshioNakatomi, KatsumiHagiwara, SachikoNinomiya, HironoriMotoi, NorikoIshikawa, YuichiHorai, TakeshiNishio, Makoto
- [5] Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancerLUNG CANCER, 2013, 81 (03) : 428 - 434Schmid-Bindert, GeraldGebbia, VittorioMayer, FrankArriola, EdurneMarquez-Medina, DiegoSyrigos, KostasBiesma, BonneLeschinger, Monika IrisFrimodt-Moller, BenteRipoche, VeroniqueMyrand, Scott P.Nguyen, Tuan S.Hozak, Rebecca R.Zimmermann, AnnamariaVisseren-Grul, CarlaSchuette, Wolfgang
- [6] EFFICACY AND SAFETY OF CISPLATIN/PEMETREXED AS FIRST-LINE TREATMENT FOR JAPANESE PATIENTS WITH ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCERRESPIROLOGY, 2013, 18 : 83 - 83Yamaguchi, TeppeiNakanishi, ToruHayashi, MasamichiIsogai, SumitoHoshino, TamiMieno, YukiUozu, SakurakoMorishita, MarikoOkamura, TakuyaTakeyama, TomokoMinezawa, TomoyukiMorikawa, SayakoNiwa, YoshikazuOkazawa, MitsushiImaizumi, Kazuyoshi
- [7] Phase II trial of bevacizumab plus pemetrexed and carboplatin in previously untreated advanced nonsquamous non-small cell lung cancerJOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Dalsania, C. J.Hageboutros, A.Harris, E.Krieger, K.Vora, C.Stevenson, J.
- [8] Phase II Study of Pemetrexed and Erlotinib in Pretreated Nonsquamous, Non-Small-Cell Lung Cancer Patients without an EGFR mutationCHEMOTHERAPY, 2013, 59 (06) : 414 - 419Kim, Young HakNishimura, TakashiOzasa, HiroakiNagai, HirokiSakamori, YuichiIwata, ToshiyukiSunadome, HironobuNishimura, TomokoMishima, Michiaki
- [9] Phase I/II trial of bortezimib and pemetrexed in patients with advanced non-small cell lung cancerJOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Natale, R. B.McKinley, M.Hilger, J.Myers, T.
- [10] Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP studyBMC CANCER, 2018, 18Tsutani, YasuhiroMiyata, YoshihiroMasuda, TakeshiFujitaka, KazunoriDoi, MihokoAwaya, YoshikazuKuyama, ShoichiKitaguchi, SoichiUeda, KazuhiroHattori, NoboruOkada, Morihito